$OCX OncoCyte Corp Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoCyte Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OncoCyte Corp. Insider overview, share value development, latest insider transactions and email notifications about new events in OncoCyte Corp for free.
IRS Number: 271041563
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: OCX
Company Address: 15 CUSHING IRVINE 92618
Phone number: 949-409-7600
Former name: OncoCyte Corp, date of change: 2015-05-13
Market Capitalization: $159.33M
Prev close: $5.45
Average Daily Volume: 19,868
Days Low: $5.31
Year Low: $2.85
Year High: $7.95
OncoCyte Corp Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | X | 3.00 | 6,993 | 20,979 | 0 | |
| Jun 14 2021 | OCX | OncoCyte Corp | Last Andrew J. | Director | Buy | X | 3.00 | 6,993 | 20,979 | 30,170 | 23.2 K to 30.2 K (+30.17 %) |
| Apr 30 2021 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
| Apr 30 2021 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Payment of Exercise | F | 0.00 | 4,620 | 0 | 62,080 | 66.7 K to 62.1 K (-6.93 %) |
| Apr 30 2021 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Buy | M | 0.00 | 20,000 | 0 | 66,700 | 46.7 K to 66.7 K (+42.83 %) |
| Mar 22 2021 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Buy | P | 4.79 | 11,000 | 52,702 | 113,698 | 102.7 K to 113.7 K (+10.71 %) |
| Mar 01 2021 | OCX | OncoCyte Corp | Sundar Padmavathi | Chief Commercial Of ... | Option Exercise | A | 5.34 | 255,000 | 1,361,700 | 255,000 | |
| Feb 09 2021 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 4.50 | 600,000 | 2,700,000 | 16,776,484 | 16.2 M to 16.8 M (+3.71 %) |
| Jan 22 2021 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 3.42 | 1,460,280 | 4,999,999 | 16,176,484 | 14.7 M to 16.2 M (+9.92 %) |
| Dec 28 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Option Exercise | M | 1.34 | 65,271 | 87,463 | 0 | |
| Dec 28 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Option Exercise | M | 1.34 | 1,237 | 1,658 | 65,271 | |
| Dec 28 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Buy | M | 1.34 | 65,271 | 87,463 | 384,111 | 318.8 K to 384.1 K (+20.47 %) |
| Dec 28 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Sell | S | 2.55 | 900 | 2,295 | 318,840 | 319.7 K to 318.8 K (-0.28 %) |
| Dec 28 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Buy | M | 1.34 | 1,237 | 1,658 | 319,740 | 318.5 K to 319.7 K (+0.39 %) |
| Dec 23 2020 | OCX | OncoCyte Corp | KINGSLEY ALFRED D | Director | Option Exercise | M | 1.34 | 10,516 | 14,091 | 66,508 |